US6262088B1
(en)
|
1998-11-19 |
2001-07-17 |
Berlex Laboratories, Inc. |
Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
|
GB9910807D0
(en)
|
1999-05-10 |
1999-07-07 |
Prometic Biosciences Limited |
Novel detoxification agents and their use
|
US6906067B2
(en)
|
1999-12-28 |
2005-06-14 |
Bristol-Myers Squibb Company |
N-heterocyclic inhibitors of TNF-α expression
|
AU783981C
(en)
|
2000-05-08 |
2007-05-03 |
Janssen Pharmaceutica N.V. |
HIV replication inhibitors
|
WO2002102313A2
(en)
|
2001-06-19 |
2002-12-27 |
Bristol-Myers Squibb Company |
Pyrimidine inhibitors of phosphodiesterase (pde) 7
|
PE20030008A1
(es)
|
2001-06-19 |
2003-01-22 |
Bristol Myers Squibb Co |
Inhibidores duales de pde 7 y pde 4
|
WO2003002544A1
(en)
|
2001-06-26 |
2003-01-09 |
Bristol-Myers Squibb Company |
N-heterocyclic inhibitors of tnf-alpha expression
|
WO2003030909A1
(en)
|
2001-09-25 |
2003-04-17 |
Bayer Pharmaceuticals Corporation |
2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
|
EP1453516A2
(de)
|
2001-10-17 |
2004-09-08 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
5-substituierte 4-amino-2-phenylamino-pyrimdinderivate und ihre verwendung als beta-amyloid modulatoren
|
WO2003032997A1
(de)
|
2001-10-17 |
2003-04-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pyrimidinderivate, arzneimittel enthaltend diese verbindungen, deren verwendung und verfahren zu ihrer herstellung
|
JP4072615B2
(ja)
|
2002-03-05 |
2008-04-09 |
独立行政法人産業技術総合研究所 |
配位子を有する複素環化合物及びその製造方法、及びこの複素環化合物を用いる金属元素の固定化膜
|
JP2006508997A
(ja)
|
2002-11-28 |
2006-03-16 |
シエーリング アクチエンゲゼルシャフト |
Chk−、Pdk−およびAkt−阻害性ピリミジン、それらの製造および薬剤としての使用
|
US7144911B2
(en)
|
2002-12-31 |
2006-12-05 |
Deciphera Pharmaceuticals Llc |
Anti-inflammatory medicaments
|
US7202257B2
(en)
|
2003-12-24 |
2007-04-10 |
Deciphera Pharmaceuticals, Llc |
Anti-inflammatory medicaments
|
US7279576B2
(en)
|
2002-12-31 |
2007-10-09 |
Deciphera Pharmaceuticals, Llc |
Anti-cancer medicaments
|
CL2004000303A1
(es)
|
2003-02-20 |
2005-04-08 |
Tibotec Pharm Ltd |
Compuestos derivados de pirimidinas y triazinas; proceso de preparacion; composicion farmaceutica; y su uso para inhibir la replicacion del vih.
|
JP2007526894A
(ja)
|
2003-07-16 |
2007-09-20 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
グリコーゲンシンターゼキナーゼ3インヒビターとしてのトリアゾロピリミジン誘導体
|
CN102358738A
(zh)
|
2003-07-30 |
2012-02-22 |
里格尔药品股份有限公司 |
2,4-嘧啶二胺化合物及其预防和治疗自体免疫疾病的用途
|
ATE506953T1
(de)
|
2003-08-07 |
2011-05-15 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidindiamin-verbindungen und verwendungen als antiproliferative mittel
|
JP4812763B2
(ja)
|
2004-05-18 |
2011-11-09 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
シクロアルキル置換ピリミジンジアミン化合物およびそれらの用途
|
WO2005121121A2
(en)
|
2004-06-04 |
2005-12-22 |
Arena Pharmaceuticals, Inc. |
Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
|
GB0512324D0
(en)
|
2005-06-16 |
2005-07-27 |
Novartis Ag |
Organic compounds
|
US20070078121A1
(en)
|
2004-12-23 |
2007-04-05 |
Flynn Daniel L |
Enzyme modulators and treatments
|
DE602005022113D1
(de)
|
2005-01-07 |
2010-08-12 |
Hoffmann La Roche |
Phenyl)methanon-derivate als glycin-transporter 1 (glyt-1) hemmer zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
|
WO2006128172A2
(en)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating b cell regulated autoimmune disorders
|
WO2006128129A2
(en)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating cancer
|
US8193206B2
(en)
|
2005-06-14 |
2012-06-05 |
Taigen Biotechnology Co., Ltd. |
Pyrimidine compounds
|
US8748627B2
(en)
|
2006-02-15 |
2014-06-10 |
Abbvie Inc. |
Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome
|
JP2009537520A
(ja)
|
2006-05-15 |
2009-10-29 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Fgf受容体キナーゼ阻害剤のための組成物および方法
|
US20070293494A1
(en)
|
2006-06-15 |
2007-12-20 |
Djung Jane F |
2-Anilino-4-(Heterocyclic) Amino-Pyrimidines
|
US8188113B2
(en)
|
2006-09-14 |
2012-05-29 |
Deciphera Pharmaceuticals, Inc. |
Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
US7897762B2
(en)
|
2006-09-14 |
2011-03-01 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of proliferative diseases
|
US7790756B2
(en)
|
2006-10-11 |
2010-09-07 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
|
CA2673965A1
(en)
|
2006-12-28 |
2008-07-10 |
Taisho Pharmaceutical Co., Ltd. |
Pyrazolopyrimidine compound
|
EA200970700A1
(ru)
|
2007-04-20 |
2010-02-26 |
ДЕСИФЕРА ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи |
Ингибиторы киназы, пригодные для лечения миелопролиферативных заболеваний и других пролиферативных заболеваний
|
CA2703203C
(en)
|
2007-10-22 |
2015-12-15 |
Schering Corporation |
Bicyclic heterocycle derivatives and methods of use thereof
|
WO2009122180A1
(en)
|
2008-04-02 |
2009-10-08 |
Medical Research Council |
Pyrimidine derivatives capable of inhibiting one or more kinases
|
EP2303277A4
(en)
|
2008-06-26 |
2011-08-17 |
Glaxosmithkline Llc |
HAMMER OF ACT ACTIVITY
|
NZ624345A
(en)
|
2008-06-27 |
2016-07-29 |
Celgene Avilomics Res Inc |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
MX2011004535A
(es)
|
2008-10-29 |
2011-11-18 |
Deciphera Pharmaceuticals Llc |
Ciclopropanamidas y analogos que exhiben actividades anti-cancer y anti-proliferativas.
|
WO2010111406A2
(en)
|
2009-03-24 |
2010-09-30 |
Myriad Pharmaceuticals, Inc. |
Compounds and therapeutic uses thereof
|
TW201100441A
(en)
|
2009-06-01 |
2011-01-01 |
Osi Pharm Inc |
Amino pyrimidine anticancer compounds
|
AU2010331927B2
(en)
|
2009-12-17 |
2013-10-10 |
Merck Canada Inc. |
Aminopyrimidines as Syk inhibitors
|
CN102812167A
(zh)
|
2009-12-30 |
2012-12-05 |
阿维拉制药公司 |
蛋白的配体-介导的共价修饰
|
US8569319B2
(en)
|
2010-04-29 |
2013-10-29 |
Deciphera Pharmaceuticals, LLS |
Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
|
DK2563362T3
(da)
|
2010-04-29 |
2014-06-23 |
Deciphera Pharmaceuticals Llc |
Cyclopropyldicarboxamider og analoger heraf, der udviser anticancer og antiproliferativ aktivitet
|
WO2012033195A1
(ja)
|
2010-09-10 |
2012-03-15 |
京都薬品工業株式会社 |
複素環化合物
|
JP5937111B2
(ja)
|
2011-02-17 |
2016-06-22 |
カンサー・セラピューティクス・シーアールシー・プロプライエタリー・リミテッドCancer Therapeutics Crc Pty Limited |
Fak阻害剤
|
AU2012288892B2
(en)
*
|
2011-07-28 |
2016-04-21 |
Cellzome Limited |
Heterocyclyl pyrimidine analogues as JAK inhibitors
|
WO2013078295A2
(en)
|
2011-11-22 |
2013-05-30 |
Deciphera Pharmaceuticals, Llc |
Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
|
BR112014009717B1
(pt)
|
2011-11-29 |
2022-06-14 |
Genentech, Inc |
Derivados de 2-(fenil ou pirid-3-il)aminopirimidina, seus usos, e composição farmacêutica
|
US9145402B2
(en)
|
2011-11-29 |
2015-09-29 |
Genentech, Inc. |
Aminopyrimidine derivatives as LRRK2 modulators
|
CA2856002C
(en)
|
2011-11-30 |
2020-10-13 |
Bryan K. Chan |
Fluorine-18 and carbon-11 labeled radioligands for positron emission tomography (pet) imaging for lrrk2
|
AR090151A1
(es)
|
2012-03-07 |
2014-10-22 |
Lilly Co Eli |
Compuestos inhibidores de raf
|
US9187474B2
(en)
|
2012-03-07 |
2015-11-17 |
Deciphera Pharmaceuticals, Llc |
Raf inhibitor compounds
|
GB201204384D0
(en)
|
2012-03-13 |
2012-04-25 |
Univ Dundee |
Anti-flammatory agents
|
US8461179B1
(en)
|
2012-06-07 |
2013-06-11 |
Deciphera Pharmaceuticals, Llc |
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
EP2888256A4
(en)
|
2012-08-24 |
2016-02-17 |
Univ Texas |
HETEROCYCLIC HIF ACTIVITY MODULATORS FOR THE TREATMENT OF DISEASES
|
US9828360B2
(en)
|
2012-11-13 |
2017-11-28 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
WO2014145015A2
(en)
|
2013-03-15 |
2014-09-18 |
Deciphera Pharmaceuticals, Llc |
Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activities
|
US9193719B2
(en)
|
2013-03-15 |
2015-11-24 |
Deciphera Pharmaceuticals, Llc |
1,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-proliferative activities
|
EP2968286B1
(en)
|
2013-03-15 |
2017-09-13 |
Deciphera Pharmaceuticals, LLC |
2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activities
|
CN112047927A
(zh)
|
2013-03-15 |
2020-12-08 |
德西费拉制药有限责任公司 |
展现抗癌和抗增殖活性的n-酰基-n′-(吡啶-2-基)脲及类似物
|
WO2014145029A2
(en)
|
2013-03-15 |
2014-09-18 |
Deciphera Pharmaceuticals, Llc |
N-acyl-n'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
|
US9012635B2
(en)
|
2013-03-15 |
2015-04-21 |
Deciphera Pharmaceuticals, Llc |
Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
|
CN103242341B
(zh)
|
2013-04-19 |
2015-12-09 |
中国科学院广州生物医药与健康研究院 |
噻吩并2,4取代嘧啶类化合物及其药物组合物与应用
|
CA2917667A1
(en)
|
2013-07-09 |
2015-01-15 |
Dana-Farber Cancer Institute, Inc. |
Kinase inhibitors for the treatment of disease
|
US9840517B2
(en)
|
2013-09-18 |
2017-12-12 |
Beijing Hanmi Pharmaceutical Co., Ltd. |
Compound inhibiting activities of BTK and/or JAK3 kinases
|
WO2015039613A1
(zh)
|
2013-09-18 |
2015-03-26 |
北京韩美药品有限公司 |
抑制btk和/或jak3激酶活性的化合物
|
AU2014337291B9
(en)
|
2013-10-18 |
2020-05-07 |
Eisai R&D Management Co., Ltd. |
Pyrimidine FGFR4 inhibitors
|
BR112016008632A8
(pt)
|
2013-10-21 |
2020-03-17 |
Merck Patent Gmbh |
compostos de heteroarila como inibidores de btk, seus usos, e composição farmacêutica
|
US9457019B2
(en)
|
2013-11-07 |
2016-10-04 |
Deciphera Pharmaceuticals, Llc |
Methods for inhibiting tie-2 kinase useful in the treatment of cancer
|
US20150284341A1
(en)
|
2014-04-07 |
2015-10-08 |
Catylix, Inc. |
Fluoroalkyl-substituted derivatives of pyridine, pyrimidine, and pyrazine
|
DK3185868T3
(da)
|
2014-08-25 |
2022-05-23 |
Salk Inst For Biological Studi |
Hidtil ukendte ULK1-inhibitorer og fremgangsmåder til anvendelse af samme
|
CN107406427A
(zh)
|
2015-02-25 |
2017-11-28 |
豪夫迈·罗氏有限公司 |
炔基醇及其使用方法
|
EP3328496A4
(en)
|
2015-08-02 |
2018-12-19 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Inhibitors of ack1/tnk2 tyrosine kinase
|
US10738016B2
(en)
|
2015-10-13 |
2020-08-11 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
BRD4-kinase inhibitors as cancer therapeutics
|
US11028080B2
(en)
*
|
2016-03-11 |
2021-06-08 |
Denali Therapeutics Inc. |
Substituted pyrimidines as LRKK2 inhibitors
|
JP7296318B2
(ja)
|
2017-02-28 |
2023-06-22 |
ザ ジェネラル ホスピタル コーポレイション |
Sikインヒビターとしてのピリミドピリミジノンの使用
|
BR112019025346A2
(pt)
|
2017-05-30 |
2020-06-30 |
Deciphera Pharmaceuticals, Inc. |
uso de 1-[4-bromo-5-[1-etil-7-(metilamino)-2-oxo-1,2-dihidro-1,6-naftiridin-3-il]-2-fluorofenil]-3-fenilureia e análogos para o tratamento de cânceres associados a anormalidades genéticas no receptor alfa do fator de crescimento derivado de plaquetas
|
CN109535132B
(zh)
*
|
2017-09-21 |
2021-07-20 |
北京赛特明强医药科技有限公司 |
2-取代吡唑氨基-4-取代氨基-5-嘧啶甲酰胺类化合物、组合物及其应用
|
SG11202007287XA
(en)
|
2018-01-31 |
2020-08-28 |
Deciphera Pharmaceuticals Llc |
Combination therapy for the treatment of mastocytosis
|
AU2019251360A1
(en)
|
2018-04-10 |
2020-10-08 |
Neuropore Therapies, Inc. |
Tri-substituted aryl and heteroaryl derivatives as modulators of PI3-kinase and autophagy pathways
|
EP3902547B1
(en)
|
2018-12-28 |
2023-09-20 |
Deciphera Pharmaceuticals, LLC |
Csf1r inhibitors for use in treating cancer
|
FI3966207T3
(fi)
|
2019-05-10 |
2023-11-30 |
Deciphera Pharmaceuticals Llc |
Autofagian fenyyliaminopyrimidiiniamidi-inhibiittoreita ja menetelmiä niiden käyttämiseksi
|
US11518758B2
(en)
|
2019-05-10 |
2022-12-06 |
Deciphera Pharmaceuticals, Llc |
Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof
|
KR20220024605A
(ko)
|
2019-06-17 |
2022-03-03 |
데시페라 파마슈티칼스, 엘엘씨. |
아미노피리미딘 아미드 자가포식 억제제 및 이의 사용 방법
|